Role of Novel CD3+CD4-CD8-Cells in Secondary Anti-Leishmania Immunity

新型 CD3 CD4-CD8 细胞在二次抗利什曼原虫免疫中的作用

• 批准号: 229609
• 负责人: Okwor Ifeoma B
• 金额: $ 7.65万
• 依托单位: University of Manitoba
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2010
• 资助国家: 加拿大
• 起止时间: 2010-10-01 至 2013-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=229609&lang=en
• 关键词: Double Negative Cells; Leismaniases; Regulation; Secondary Immunity; Vaccine

Leishmaniases are parasitic diseases that affect both humans and animals. It is caused by species of protozoan parasite belonging to the genus Leishmania, and is transmitted by the bite of female Sand files. The disease is endemic in 88 countries and it i

利什曼病是影响人类和动物的寄生虫病。它是由属于利什曼原虫属的原生动物寄生虫引起的，并通过雌性沙锥虫的叮咬传播。这种疾病在88个国家流行，